Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 30, Issue 6, Pages 307-315
http://dx.doi.org/10.3233/DMA-2011-0789

Clinical Utility of Alpha Fetoprotein and HCCR-1, Alone or in Combination, in Patients with Chronic Hepatitis, Liver Cirrhosis and Hepatocellular Carcinoma

Peng Jirun,1 Guoxin Zhang,2 Hyun Kee Kim,3 Seon-Ah Ha,3 Jin Zhongtian,1 Qiao Shishi,1 Cui Zhuqingqing,1 Gong Lei,1 Jinah Yoo,3 Sanghee Kim,3 Yong Gyu Park,5 Jing Wang,2 Yang Yang,2 Zekuan Xu,2 Zuhu Huang,2 Yun Kyung Lee,3 Eun Young Song,6 and Jin Woo Kim3,4

1Department of Surgery, Peking University People’s Hospital, Beijing, China
2Department of Gastroenterology, The first affiliated hospital of Nanjing Medical University, Nanjing, China
3Molecular Genetic Laboratory, College of Medicine, The Catholic University of Korea, Seoul 137-040, Republic of Korea
4Departments of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul 137-040, Republic of Korea
5Departments of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul 137-040, Republic of Korea
6The Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

Received 28 June 2011; Accepted 28 June 2011

Copyright © 2011 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Peng Jirun, Guoxin Zhang, Hyun Kee Kim, et al., “Clinical Utility of Alpha Fetoprotein and HCCR-1, Alone or in Combination, in Patients with Chronic Hepatitis, Liver Cirrhosis and Hepatocellular Carcinoma,” Disease Markers, vol. 30, no. 6, pp. 307-315, 2011. https://doi.org/10.3233/DMA-2011-0789.